Borroni, Riccardo G., et al. “Real-Life Effectiveness and Safety of Risankizumab in Moderate-to-Severe Plaque Psoriasis: A 40-Week Multicentric Retrospective Study”. Acta Dermato-Venereologica, vol. 101, no. 11, Nov. 2021, p. adv00605, doi:10.2340/actadv.v101.283.